Literature DB >> 11929813

Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.

Naomoto Harada1, Hiroyuki Miyoshi, Naomi Murai, Hiroko Oshima, Yoshitaka Tamai, Masanobu Oshima, Makoto M Taketo.   

Abstract

Mutations in the glycogen synthase kinase 3beta (GSK3beta) phosphorylation sites of the beta-catenin gene exon 3 are found in 20-30% of human primary hepatocellular carcinoma (HCC), whereas mutations in the APC or AXIN genes are found in other HCC populations. These data strongly suggest that the Wnt signaling pathway is involved in hepatocarcinogenesis. To determine the role of beta-catenin in intestinal tumorigenesis, we earlier constructed a mutant mouse strain Catnb(lox(ex3)), in which exon 3 of the beta-catenin gene was sandwiched by loxP sequences. By genetic crosses of these mice with the Fabpl-cre transgenic mice that express the cre gene controlled by the fatty acid binding protein gene promoter, we introduced the beta-catenin stabilizing mutation into the small intestine and liver. Although numerous polyps were formed in the small intestine, we did not find any neoplastic (i.e., dysplastic) foci in the liver, and the mice died in 5 weeks after birth because of acute liver damage accompanying mitochondrial swelling. When a recombinant adenovirus that expresses the cre gene from a human cytomegalovirus early gene promoter was constructed and inoculated at a high multiplicity (10(9) plaque-forming units/mouse), the Catnb(lox(ex3)) mice showed marked hepatomegaly, with similar mitochondrial swelling in the hepatocytes, and died within 3 weeks after infection. On the other hand, when inoculated at lower multiplicities of infection (10(7) and 10(8) plaque-forming units/mouse, respectively), the Catnb(lox(ex3)) mice survived >6 months without any neoplastic foci in the liver, although the nuclear localization of beta-catenin was found in some hepatocytes even after 6 months. These results suggest that, in contrast to intestinal polyposis, the Wnt pathway activation by stabilized beta-catenin is not sufficient for hepatocarcinogenesis, but additional mutations or epigenetic changes may be required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929813

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  Morphogenesis of chicken liver: identification of localized growth zones and the role of beta-catenin/Wnt in size regulation.

Authors:  Sanong Suksaweang; Chih-Min Lin; Ting-Xin Jiang; Michael W Hughes; Randall B Widelitz; Cheng-Ming Chuong
Journal:  Dev Biol       Date:  2004-02-01       Impact factor: 3.582

2.  Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.

Authors:  Owen J Sansom; Karen R Reed; Anthony J Hayes; Heather Ireland; Hannah Brinkmann; Ian P Newton; Eduard Batlle; Patricia Simon-Assmann; Hans Clevers; Inke S Nathke; Alan R Clarke; Douglas J Winton
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

Review 3.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

4.  Effect of mutant β-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice.

Authors:  Timothy J Stein; Adam Jochem; Katie E Holmes; Eric P Sandgren
Journal:  Liver Int       Date:  2011-01-19       Impact factor: 5.828

5.  Wnt/beta-catenin signaling in hepatic organogenesis.

Authors:  Kari Nejak-Bowen; Satdarshan Ps Monga
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

6.  β-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Xiao-Mei Gao; Chao-Qun Wang; Xiang-Yu Wang; X U Lu; Jin-Wang Wei; Kai-Li Zhang; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Mol Clin Oncol       Date:  2015-05-15

7.  Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Authors:  Sarah A Comerford; Elizabeth A Hinnant; Yidong Chen; Hima Bansal; Shawn Klapproth; Dinesh Rakheja; Milton J Finegold; Dolores Lopez-Terrada; Kathryn A O'Donnell; Gail E Tomlinson; Robert E Hammer
Journal:  JCI Insight       Date:  2016-10-06

Review 8.  Wnt signaling in liver cancer.

Authors:  Yutaka Takigawa; Anthony M C Brown
Journal:  Curr Drug Targets       Date:  2008-11       Impact factor: 3.465

9.  Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.

Authors:  Haluk Yuzugullu; Khemais Benhaj; Nuri Ozturk; Serif Senturk; Emine Celik; Asli Toylu; Nilgun Tasdemir; Mustafa Yilmaz; Esra Erdal; Kamil Can Akcali; Nese Atabey; Mehmet Ozturk
Journal:  Mol Cancer       Date:  2009-10-22       Impact factor: 27.401

10.  Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo.

Authors:  Michael Buchert; Dimitris Athineos; Helen E Abud; Zoe D Burke; Maree C Faux; Michael S Samuel; Andrew G Jarnicki; Catherine E Winbanks; Ian P Newton; Valerie S Meniel; Hiromu Suzuki; Steven A Stacker; Inke S Näthke; David Tosh; Joerg Huelsken; Alan R Clarke; Joan K Heath; Owen J Sansom; Matthias Ernst
Journal:  PLoS Genet       Date:  2010-01-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.